Home >> Marketplace Archives >> Health Canada approves Panther Fusion

Health Canada approves Panther Fusion

Print Friendly, PDF & Email

August 2018—Hologic has obtained approval from Health Canada for its Panther Fusion system and Panther Fusion assays for respiratory virus infections. The Panther Fusion module adds the capacity to run PCR assays in addition to tests based on transcription-mediated amplification, the proprietary Hologic chemistry that powers the company’s Aptima brand.

The Panther Fusion respiratory assays include the Panther Fusion Flu A/B/RSV, Paraflu, and AdV/hMPV/RV tests and offer a modular approach to syndromic testing via the ability to run one, two, or all three assays from a single patient specimen.

Hologic, 508-263-2900


Check Also

Panther Fusion GBS assay cleared

October 2018—Hologic received FDA clearance for its group B Streptococcus assay on the Panther Fusion system. The Panther Fusion GBS assay is a real-time PCR assay for the qualitative detection of group B strep in antepartum women with dual-target detection of Cfb and SIP genes.